Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 6,317 | 7,832 | 5,926 | 6,102 | 3,584 |
| Operating Income | -6,317 | -7,832 | -5,926 | -6,102 | -3,584 |
| Interest Expense | 22 | 22 | 22 | 21 | 22 |
| Other Income | 1 | 2 | 5 | 9 | 50 |
| Pre-tax Income | -6,338 | -7,852 | -5,943 | -6,114 | -3,556 |
| Net Income Continuous | -6,338 | -7,852 | -5,943 | -6,114 | -3,556 |
| Net Income | $-6,338 | $-7,852 | $-5,943 | $-6,114 | $-3,556 |
| EPS Basic Total Ops | -0.11 | -0.14 | -0.10 | -0.11 | -0.06 |
| EPS Basic Continuous Ops | -0.11 | -0.14 | -0.10 | -0.11 | -0.06 |
| EPS Diluted Total Ops | -0.11 | -0.14 | -0.10 | -0.11 | -0.06 |
| EPS Diluted Continuous Ops | -0.11 | -0.14 | -0.10 | -0.11 | -0.06 |
| EBITDA(a) | $-6,307 | $-7,823 | $-5,916 | $-6,094 | $-3,575 |